Bone marrow or peripheral blood samples were collected, after informed consent was obtained, from both pediatric (n=42) and adult (n=38) AML patients at initial diagnosis and at relapse. All included ...
iCare 1: A prospective clinical trial to predict treatment response based on genomics-informed computational biology in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback